PharmaKB logo
Company Reports
Company Reports
Drug Reports
Drug Reports
Disease Reports
Disease Reports
Sets
Sets
Favorites
Favorites
Log in
Log in
AboutPricing
Company ReportsOlympus Biotech
Olympus Biotech
Download report
Favorite
Financial
Marketed Drugs
Clinical Trials
Financial
Stock price
No data
Company Revenue
No data
Revenue by Drug
Loading
Marketed Drugs
Therapeutic Areas:
All
Classification:
All
Include Generics:
Trade Name
Drug Name
Approved
Patent Expires
Indication
OpgenraEptotermin alfa2009-02-19
Spondylolisthesis
,
Tibial fractures
OsigraftEptotermin alfa2001-05-17
Spondylolisthesis
,
Tibial fractures
Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Drug Name
Phase 1
Phase 2
Phase 3
Phase 4
Indication
Eptotermin alfa
healthy volunteers/patients
,
knee osteoarthritis
,
osteoarthritis
,
malocclusion
,
cataract
,
carcinoma
,
oropharyngeal neoplasms
,
alzheimer disease
,
tibial fractures
,
spondylolisthesis
,
osteonecrosis
,
femur head necrosis
,
necrosis
,
intervertebral disc degeneration
,
joint diseases
,
sleep wake disorders
,
dyssomnias
,
parasomnias
Trafermin
periodontitis
,
diabetic foot
,
ulcer
,
foot ulcer
,
tympanic membrane perforation
,
alveolar bone loss
,
periodontal attachment loss
Aspartame
hiv
,
bronchiectasis
,
escherichia coli infections
,
gastroenteritis
,
pharmacokinetics
,
dental plaque
,
hydrogen-ion concentration
,
salivation
,
healthy volunteers/patients
,
xerostomia
,
sjogren's syndrome
,
ototoxicity
,
mucositis
,
glioblastoma
,
covid-19
,
pyruvate dehydrogenase complex deficiency disease
,
sepsis
,
malnutrition
,
child nutrition disorders
,
colonoscopy
,
obesity
,
type 2 diabetes mellitus
,
overweight
,
diabetes mellitus
,
glucose intolerance
,
body weight
,
insulin resistance
,
metabolic syndrome
,
weight loss
,
feeding behavior
,
glucose metabolism disorders
,
metabolic diseases
,
abdominal obesity
,
adiposity
,
dyslipidemias
,
prediabetic state
,
glucose tolerance test
,
cognition
,
fasting
,
type 1 diabetes mellitus
,
placebos
,
hypoglycemia
,
gastric bypass
,
congenital hyperinsulinism
,
nesidioblastosis
,
driving under the influence
,
glycogen storage disease type iii
,
glycogen storage disease
,
kidney transplantation
,
hyperglycemia
,
sleep deprivation
,
cardiovascular diseases
,
mortality
,
hypersensitivity
,
gastrointestinal microbiome
,
chronic disease
,
neoplasms
,
diet
,
adolescent development
,
acromegaly
,
appetitive behavior
,
microbiota
,
chronic periodontitis
,
periodontitis
,
thirst
,
pregnancy rate
,
atherosclerosis
,
appetite
,
intestinal absorption
,
taste
,
hypoxia
,
blood glucose self-monitoring
,
deglutition disorders
,
syndrome
,
thrombosis
,
inflammation
,
platelet aggregation
,
wounds and injuries
,
spinal cord injuries
,
cold temperature
,
sleep
,
blood pressure
,
vascular stiffness
,
aging
,
exercise tolerance
,
alcohol drinking
Bevifimod
short bowel syndrome
,
syndrome
© 2020-2025 Collaborative Drug Discovery Inc. (CDD) | Terms of Use